Skip to main content

Shehnaaz Suliman, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Ultragenyx Pharmaceutical Inc. publishes a filing, an earnings call transcript or a press release.

Get RARE alerts

About Shehnaaz Suliman, M.D.

Shehnaaz Suliman, M.D. is recorded as Board Member at Ultragenyx Pharmaceutical Inc. (RARE) since June 7, 2023. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed May 18, 2026 a re-election or new board role (Class I Director) for Shehnaaz Suliman, M.D., on the board since at least 2023, effective May 14, 2026. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed June 13, 2023 that Shehnaaz Suliman, M.D. was appointed Class I Director, effective June 7, 2023. Ultragenyx Pharmaceutical Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ultragenyx Pharmaceutical Inc. includes Emil D. Kakkis (CEO and Board Member), Emil Kakkis (CEO and Board Member), Howard Horn (CFO) and 7 others.

“At the Annual Meeting, the Company's stockholders elected the Class I director nominees below to the Company's Board of Directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected.”
Ultragenyx Pharmaceutical Inc. Form 8-K, filed May 18, 2026 · Read the filing
“At the Annual Meeting, the Company's stockholders elected the Class I director nominees below to the Company's Board of Directors to hold office until the 2026 Annual Meeting of Stockholders or until their successors are elected.”
Ultragenyx Pharmaceutical Inc. Form 8-K, filed June 13, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Ultragenyx Pharmaceutical Inc.

Recent activity